H. Y. Yu, O. ., Filliter, C. ., Filion, K. B., Platt, R. W., Grad, R. ., & Renoux, C. . (2024). Levothyroxine Treatment of Subclinical Hypothyroidism and the Risk of Adverse Cardiovascular Events. Thyroid. http://doi.org/10.1089/thy.2024.0227
C. Filliter
First name
C.
Last name
Filliter
Engler, J. ., Filliter, C. ., Montastruc, F. ., Abenhaim, H. ., Rej, S. ., & Renoux, C. . (2024). Risk of abnormal uterine bleeding associated with high-affinity compared with low-affinity serotonin and norepinephrine reuptake inhibitors. J Affect Disord, 350, 813–821. http://doi.org/10.1016/j.jad.2024.01.163
Larose, S. ., Filliter, C. ., Platt, R. W., H. Y. Yu, O. ., & Filion, K. B. (2023). Long-acting insulin analogues and the risk of diabetic retinopathy among patients with type 2 diabetes: A population-based cohort study. Diabetes Obes Metab. http://doi.org/10.1111/dom.15106
Aloe, S. ., Filliter, C. ., Salmasi, S. ., Igweokpala, S. ., H. Y. Yu, O. ., Tagalakis, V. ., & Filion, K. B. (2023). SGLT2 Inhibitors and the Risk of Venous Thromboembolism: A Population-based Cohort Study. Br J Clin Pharmacol. http://doi.org/10.1111/bcp.15787
Cao, T. X. D., Filliter, C. ., Montastruc, F. ., H. Y. Yu, O. ., Fergusson, E. ., Rej, S. ., … Renoux, C. . (2022). Selective serotonin reuptake inhibitors and the risk of type 2 diabetes mellitus in youths. J Affect Disord, 318, 231–237. http://doi.org/10.1016/j.jad.2022.08.094